Antti Jylha

1silk, Pl 100
Tampere, 33014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Ceramide-phospholipid risk score associates with cardiovascular events and is lowered by atorvastatin, simvastatin and anti-PCSK9 treatments.

Ceramide-phospholipid risk score associates with cardiovascular events and is lowered by atorvastatin, simvastatin and anti-PCSK9 treatments.

Journal: Journal of cardiovascular pharmacology

Published: July 10, 2026

Advantage of analysing drug paraphernalia in cause-of-death investigations.

Advantage of analysing drug paraphernalia in cause-of-death investigations.

Journal: Forensic science international

Published: October 24, 2025

Ceramide-Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments.

Ceramide-Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments.

Journal: Journal of cardiovascular pharmacology

Published: October 16, 2025

Post-Mortem Identification and Toxicological Findings of Fluetonitazepyne and Isotonitazepyne.

Post-Mortem Identification and Toxicological Findings of Fluetonitazepyne and Isotonitazepyne.

Journal: Drug testing and analysis

Published: May 21, 2025

Association of ceramide risk scores with rheumatoid arthritis: a FINRISK population-based cohort study.

Association of ceramide risk scores with rheumatoid arthritis: a FINRISK population-based cohort study.

Journal: BMJ open

Published: March 12, 2025

Exploring the association between ceramide, phosphatidylcholine, and COPD prevalence and incidence: a FINRISK population-based cohort study.

Exploring the association between ceramide, phosphatidylcholine, and COPD prevalence and incidence: a FINRISK population-based cohort study.

Journal: BMC pulmonary medicine

Published: February 17, 2025

Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure.

Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure.

Journal: European journal of clinical investigation

Published: September 09, 2024

Phosphatidylethanol is a promising tool for screening alcohol consumption during pregnancy.

Phosphatidylethanol is a promising tool for screening alcohol consumption during pregnancy.

Journal: Alcohol, clinical & experimental research

Published: April 30, 2024

The Novel Ceramide- and Phosphatidylcholine-Based Risk Score for the Prediction of New-Onset of Hypertension.

The Novel Ceramide- and Phosphatidylcholine-Based Risk Score for the Prediction of New-Onset of Hypertension.

Journal: Journal of clinical medicine

Published: September 30, 2023

Serum ceramides in early pregnancy as predictors of gestational diabetes.

Serum ceramides in early pregnancy as predictors of gestational diabetes.

Journal: Scientific reports

Published: May 03, 2023

Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly.

Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly.

Journal: Clinical chemistry

Published: December 23, 2021

Coffee, Atrial Fibrillation, and Circulating Ceramides in Patients with Chronic Heart Failure.

Coffee, Atrial Fibrillation, and Circulating Ceramides in Patients with Chronic Heart Failure.

Journal: Journal of agricultural and food chemistry

Published: September 17, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026